tradingkey.logo
tradingkey.logo
Buscar

Xtant Medical Holdings Inc

XTNT
Añadir a la lista de seguimiento
0.456USD
-0.014-2.91%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
63.95MCap. mercado
34.64P/E TTM

Xtant Medical Holdings Inc

0.456
-0.014-2.91%

Más Datos de Xtant Medical Holdings Inc Compañía

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Información de Xtant Medical Holdings Inc

Símbolo de cotizaciónXTNT
Nombre de la empresaXtant Medical Holdings Inc
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoBrowne (Sean E)
Número de empleados217
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 30
Dirección664 Cruiser Lane
CiudadBELGRADE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal59714
Teléfono14063880480
Sitio Webhttps://xtantmedical.com/
Símbolo de cotizaciónXTNT
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoBrowne (Sean E)

Ejecutivos de Xtant Medical Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
122.45M
91.43%
Rest of World
11.48M
8.57%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
Otro
34.56%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
Otro
34.56%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
49.89%
Individual Investor
13.86%
Investment Advisor/Hedge Fund
5.61%
Investment Advisor
2.41%
Research Firm
0.03%
Otro
28.20%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
41
80.10M
114.61%
--
2026Q1
63
83.43M
59.56%
-78.98M
2025Q4
60
79.98M
57.13%
-82.26M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Dec 31, 2025
Lytton (Laurence W)
7.70M
5.5%
-1.76M
-18.61%
Dec 31, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
--
--
Dec 31, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Renaissance Technologies LLC
919.86K
0.66%
+205.94K
+28.85%
Dec 31, 2025
Bakewell (John K)
914.12K
0.65%
+158.23K
+20.93%
Nov 15, 2025
Geode Capital Management, L.L.C.
491.95K
0.35%
--
--
Dec 31, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI